Cargando…
Plasma fetuin-A/α2-HS-glycoprotein correlates negatively with inflammatory cytokines, chemokines and activation biomarkers in individuals with type-2 diabetes
BACKGROUND: Fetuin-A/AHSH is a novel hepatokine that acts as a vascular calcification inhibitor and as an endogenous TLR-4 ligand. Fetuin-A may act as a positive or negative acute phase protein (APP) in disease conditions. The relationship between circulatory fetuin-A and inflammatory biomarkers in...
Autores principales: | Sindhu, Sardar, Akhter, Nadeem, Shenouda, Steve, Wilson, Ajit, Ahmad, Rasheed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037637/ https://www.ncbi.nlm.nih.gov/pubmed/27671862 http://dx.doi.org/10.1186/s12865-016-0171-y |
Ejemplares similares
-
TLR4/MyD88 -mediated CCL2 production by lipopolysaccharide (endotoxin): Implications for metabolic inflammation
por: Akhter, Nadeem, et al.
Publicado: (2018) -
Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes
por: Sindhu, Sardar, et al.
Publicado: (2017) -
Allelic Imbalance of mRNA Associated with α2-HS Glycoprotein (Fetuin-A) Polymorphism
por: Inaoka, Yoshihiko, et al.
Publicado: (2015) -
Fetuin‐A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high‐grade astrocytomas
por: Nangami, Gladys N., et al.
Publicado: (2016) -
The Cooperative Induction of CCL4 in Human Monocytic Cells by TNF-α and Palmitate Requires MyD88 and Involves MAPK/NF-κB Signaling Pathways
por: Sindhu, Sardar, et al.
Publicado: (2019)